Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Going forward, pharma teams that proactively adapt their market-access playbook to this constrained environment will be best positioned to capture the opportunity of the GLP-1 revolution while serving patient needs
Some case reports and clinical observations suggest that GLP-1 medications might help people with lipedema through weight loss, improved metabolism, and reduced inflammation
Firms with 10 to 199 workers are more likely than larger employers to believe their employees have no concern about their ability to schedule timely appointments with providers (31% vs
the path from rodent studies to validated human outcomes is long and uncertain
Shared decision-making between the patient and their care team is indicated to decide whether to start, continue or discontinue GLP-1 therapy in the setting of a new diagnosis of NAION or in certain risk contexts, considering the individual patient characteristics and clinical scenario, the guidance article authors wrote
Understanding the intersection of autoimmune disease and modern weight loss therapy requires both clinical evidence and individualized medical oversight
